CRL
Price
$201.41
Change
+$29.27 (+17.00%)
Updated
Feb 3 closing price
Capitalization
9.91B
14 days until earnings call
Intraday BUY SELL Signals
TMO
Price
$570.09
Change
+$35.41 (+6.62%)
Updated
Feb 3 closing price
Capitalization
214.19B
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRL vs TMO

Header iconCRL vs TMO Comparison
Open Charts CRL vs TMOBanner chart's image
Charles River Laboratories International
Price$201.41
Change+$29.27 (+17.00%)
Volume$963.82K
Capitalization9.91B
Thermo Fisher Scientific
Price$570.09
Change+$35.41 (+6.62%)
Volume$2.25M
Capitalization214.19B
CRL vs TMO Comparison Chart in %
View a ticker or compare two or three
VS
CRL vs. TMO commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Hold and TMO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (CRL: $201.41 vs. TMO: $570.09)
Brand notoriety: CRL and TMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 141% vs. TMO: 109%
Market capitalization -- CRL: $9.91B vs. TMO: $214.19B
CRL [@Medical Specialties] is valued at $9.91B. TMO’s [@Medical Specialties] market capitalization is $214.19B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $12.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 2 FA rating(s) are green whileTMO’s FA Score has 0 green FA rating(s).

  • CRL’s FA Score: 2 green, 3 red.
  • TMO’s FA Score: 0 green, 5 red.
According to our system of comparison, CRL is a better buy in the long-term than TMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 4 TA indicator(s) are bullish while TMO’s TA Score has 5 bullish TA indicator(s).

  • CRL’s TA Score: 4 bullish, 4 bearish.
  • TMO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TMO is a better buy in the short-term than CRL.

Price Growth

CRL (@Medical Specialties) experienced а -8.25% price change this week, while TMO (@Medical Specialties) price change was -8.63% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.81%. For the same industry, the average monthly price growth was +2.33%, and the average quarterly price growth was +23.01%.

Reported Earning Dates

CRL is expected to report earnings on Feb 18, 2026.

TMO is expected to report earnings on Apr 29, 2026.

Industries' Descriptions

@Medical Specialties (-4.81% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($214B) has a higher market cap than CRL($9.91B). CRL has higher P/E ratio than TMO: CRL (577.05) vs TMO (32.14). CRL YTD gains are higher at: 0.968 vs. TMO (-1.615). TMO has higher annual earnings (EBITDA): 11.3B vs. CRL (516M). TMO has more cash in the bank: 1.12B vs. CRL (207M). CRL has less debt than TMO: CRL (2.63B) vs TMO (35.7B). TMO has higher revenues than CRL: TMO (43.7B) vs CRL (4.02B).
CRLTMOCRL / TMO
Capitalization9.91B214B5%
EBITDA516M11.3B5%
Gain YTD0.968-1.615-60%
P/E Ratio577.0532.141,796%
Revenue4.02B43.7B9%
Total Cash207M1.12B18%
Total Debt2.63B35.7B7%
FUNDAMENTALS RATINGS
CRL vs TMO: Fundamental Ratings
CRL
TMO
OUTLOOK RATING
1..100
6961
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
9059
PRICE GROWTH RATING
1..100
1152
P/E GROWTH RATING
1..100
163
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TMO's Valuation (66) in the Medical Specialties industry is in the same range as CRL (94) in the Miscellaneous Commercial Services industry. This means that TMO’s stock grew similarly to CRL’s over the last 12 months.

TMO's Profit vs Risk Rating (77) in the Medical Specialties industry is in the same range as CRL (100) in the Miscellaneous Commercial Services industry. This means that TMO’s stock grew similarly to CRL’s over the last 12 months.

TMO's SMR Rating (59) in the Medical Specialties industry is in the same range as CRL (90) in the Miscellaneous Commercial Services industry. This means that TMO’s stock grew similarly to CRL’s over the last 12 months.

CRL's Price Growth Rating (11) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for TMO (52) in the Medical Specialties industry. This means that CRL’s stock grew somewhat faster than TMO’s over the last 12 months.

CRL's P/E Growth Rating (1) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for TMO (63) in the Medical Specialties industry. This means that CRL’s stock grew somewhat faster than TMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLTMO
RSI
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
57%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
52%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 29 days ago
69%
Bullish Trend 14 days ago
61%
Declines
ODDS (%)
Bearish Trend 6 days ago
70%
Bearish Trend 6 days ago
62%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signal:
Gain/Loss:
TMO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BIV77.530.03
+0.04%
Vanguard Interm-Term Bond ETF
CIL56.91N/A
N/A
VictoryShares International Vol Wtd ETF
HSBH96.78N/A
N/A
HSBC HOLDINGS PLC ADRHEDGED HSBH
GIGB46.22-0.02
-0.04%
Goldman Sachs Acss Invmt Grd Corp Bd ETF
YBTC24.16-0.69
-2.78%
Roundhill Bitcoin Covered Cll Strat ETF

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been loosely correlated with A. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if CRL jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-5.54%
A - CRL
66%
Loosely correlated
-2.40%
MTD - CRL
64%
Loosely correlated
-1.13%
RVTY - CRL
64%
Loosely correlated
-5.57%
TMO - CRL
59%
Loosely correlated
-2.01%
WAT - CRL
59%
Loosely correlated
-0.09%
More

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with DHR. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
-2.01%
DHR - TMO
80%
Closely correlated
-3.05%
A - TMO
80%
Closely correlated
-2.40%
MTD - TMO
76%
Closely correlated
-1.13%
RVTY - TMO
74%
Closely correlated
-5.57%
WAT - TMO
71%
Closely correlated
-0.09%
More